Observational and Genetic Evidence Reveals the Effect of Serum Lipid Levels on COPD Risk
Our study identified associations between TC, non-HDL-C, and LDL-C with a reduced risk of COPD. This underscores the importance of monitoring lipid metabolism in patients with COPD and provides supporting evidence for the use of lipid-based therapies in its treatment.
Authors
- Tao Guo (ORCID: https://orcid.org/0009-0005-6774-2935)
- Chengshi He (ORCID: https://orcid.org/0000-0002-6879-4383)
- Lei Liu (ORCID: https://orcid.org/0000-0003-1778-756X)
- Guobing Jia (ORCID: https://orcid.org/0009-0004-1089-0841)
Institutions
- First People's Hospital of Chongqing (CN)
- Chengdu University of Traditional Chinese Medicine (CN)
Publication Details
- Journal
- International Journal of COPD
- Published
- 2025-08-01
- DOI
- https://doi.org/10.2147/copd.s503030
- Citations
- 1
- Primary Topic
- Chronic Obstructive Pulmonary Disease (COPD) Research
- Type
- article
- Field-Weighted Citation Impact
- 1.52